Marksans Pharma Limited (MARKSANS.NS) NSE

164.29

-0.09(-0.05%)

Updated at September 29 01:12PM

Currency In INR

Valuation

Market Cap100.57B
Enterprise Value96.74B
P/E Ratio21.17
PEG Ratio-2.65
Price/Sales Ratio2.8
Price/Book Ratio3.01
Enterprise/Revenue2.66
Enterprise/EBITDA12.98

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.13
Operating Margin0.23

Management Effectiveness

Return On Assets0.11
Return On Equity0.15

Income Statement

Revenue26.23B
Revenue/Share58.67
Gross Profit14.79B
EBITDA5.29B
Net Income3.81B
Diluted EPS8.4

Balance Sheet

Total Cash7.05B
Total Cash/Share20.2
Total Debt3.22B
Total Debt/Equity0.13
Current Ratio4.62
Book Value Per Share55.07

Price History

52-Week Change-44.95
52-Week High358.7
52-Week Low162.51
Moving Average 50 Days191.75
Moving Average 200 Days228.77

Statistics

Average Volume1.47M
Shares Outstanding453.16M
% Held by Institutions0.14

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield0.49
Payout Ratio0
Last Split Factor10:1
Last Split DateMarch 11, 2008